Mind Medicine (MindMed), Inc.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: CA60255C8850

USD

12.43

0.37 (3.07%)

Dec 04

NAS

Click here to see other stocks

Company CV

About Mind Medicine (MindMed), Inc.

stock-summary

Mind Medicine (MindMed), Inc.

Pharmaceuticals & Biotechnology

Mind Medicine (MindMed) Inc., formerly Broadway Gold Mining Ltd., is a neuro-pharmaceutical company. The Company discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The Company addresses the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine.

Company Coordinates

Company Details

1166 Alberni Street, Suite 1604 , VANCOUVER BC : V6E 3Z3

stock-summary

Tel: 1 604 7614689

stock-summary

http://broadwaymining.com/

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Domestic Funds

Held in 28 Schemes (12.62%)

Foreign Institutions

Held by 68 Foreign Institutions (8.62%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

Mr. Stephen Hurst

Executive Chairman of the board, Co-Chief Executive Officer, Founder, Secretary

Ms. Miriam Wernli

President, Director

Mr. Jamon Rahn

Co-Chief Executive Officer, Founder, Director

Mr. Perry Dellelce

Independent Director

Dr. Stanley Glick

Independent Director

Mr. Bruce Linton

Independent Director

Ms. Brigid Makes

Independent Director

Stock DNA

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-43 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 714 Million ()

P/E

NA (Loss Making)

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

-0.76

Return on Equity

-66.23%

Price to Book

3.85